首页> 美国卫生研究院文献>Infection and Drug Resistance >Co-Incidence of Type II Topoisomerase Mutations and Efflux Expression in High Fluoroquinolone Resistant Enterococcus faecalis Isolated from Urinary Tract Infections
【2h】

Co-Incidence of Type II Topoisomerase Mutations and Efflux Expression in High Fluoroquinolone Resistant Enterococcus faecalis Isolated from Urinary Tract Infections

机译:II型Topoisomerase突变的共发病率和高氟喹啉酮抗肠病粪便中泌尿道感染中的耐肠道肠球菌的出发率

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Enterococcus faecalis is one of the most common pathogens in urinary tract infections (UTIs). Fluoroquinolones have been frequently used to treat E. faecalis UTIs, and the emergence of fluoroquinolone-resistant E. faecalis strains has recently been reported in several countries. This study aimed to elucidate the mechanisms involved in fluoroquinolone resistance in clinical E. faecalis isolates by analyzing mutations in quinolone- resistance-determining regions (QRDRs) of gyrA and parC and investigating the role of some efflux pumps.
机译:肠球菌粪便是泌尿道感染中最常见的病原体之一(UTI)。氟代喹啉酮经常用于治疗E.粪便utis,最近报告了几个国家的氟代喹啉酮抗e.粪便粪便菌株。本研究旨在通过分析Gyra和Parc的喹诺酮抗性测定区(QRDRS)中的突变来阐明临床大肠杆菌抗性中含氟喹啉抗性的机制,并研究了一些流出泵的作用。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号